Patent ID: 11865185
Assignee: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  C | IPC A  C

Claim 20:
21. A method for targeting hepatocytes, retina, lung, heart, kidney, liver, brain, spleen, tumor or muscle cells, Retinal Pigmented Epithelium, photoreceptors, myocytes or cardiomyocytes with the recombinant Adeno-Associated Virus (rAAV) vector particle according to claim 1 in a subject in need thereof, the method comprising at least a step of administering to said subject a composition comprising said rAAV vector particle, wherein said Recombinant Adeno-Associated Virus (rAAV) vector particle has a selective tropism for hepatocytes, retina, lung, heart, kidney, liver, brain, spleen, tumor or muscle cells.